Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
P. Maillart
Observed names:
P Maillart,
Philippe J. Maillart,
Philippe Maillart
Institution:
Institut de Cancérologie de l'Ouest
Observed institutions:
Centre Léon Bérard,
Institut de Cancérologie de l'Ouest,
Centre Eugène Marquis,
Centre Hospitalier Universitaire d'Angers,
Centre François Baclesse,
Centre Jean Perrin,
Institut Bergonié,
Centre Antoine Lacassagne,
Centre Henri Becquerel,
Institut Curie
show all 10
OpenAlex ID:
A5018360318
Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU
1996
·
Erick C. Gamelin
, Etienne M. Danquechin-Dorval
, et al.
·
Cancer
·
224
PDF
Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.
1998
·
E Gamelin
, M Boisdron-Celle
, et al.
·
Journal of Clinical Oncology
·
167
Randomized Parallel Study of Doxorubicin Plus Paclitaxel and Doxorubicin Plus Cyclophosphamide As Neoadjuvant Treatment of Patients With Breast Cancer
2004
·
Véronique Diéras
, Pierre Fumoleau
, et al.
·
Journal of Clinical Oncology
·
161
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
2019
·
Xavier Pivot
, Gilles Romieu
, et al.
·
The Lancet
·
143
PDF
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study
2017
·
H. Bourgeois
, F. Grudé
, et al.
·
Annals of Oncology
·
57
PDF
Metastatic Gastric Cancer Arising from Breast Carcinoma: Endoscopic Ultrasonographic Aspects
1998
·
G. Lorimier
, C. Binelli
, et al.
·
Endoscopy
·
37
Long-term pharmacokinetic behavior of platinum after cisplatin administration
1995
·
Erick Gamelin
, Pierre Allain
, et al.
·
Cancer Chemotherapy and Pharmacology
·
37
Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen
1992
·
E. Garcia-Giralt
, Y. Ayme
, et al.
·
Breast Cancer Research and Treatment
·
35
Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer
2001
·
M Namer
, P Soler-Michel
, et al.
·
European Journal of Cancer
·
29
[Acute cardiac toxicity of 5-fluorouracil: pharmacokinetic correlation].
1991
·
E Gamelin
, L Gamelin
, et al.
·
PubMed
·
13
Efficacy and safety of trastuzumab plus vinorelbine as second-line treatment for women with HER2-positive metastatic breast cancer beyond disease progression
2007
·
T. Bachelot
, L. Mauriac
, et al.
·
Journal of Clinical Oncology
·
9
Suppression of heparinization of central venous catheters between cycles of chemotherapy: Results of a phase I study
1998
·
R. Delva
, E. Gamelin
, et al.
·
Supportive Care in Cancer
·
9
Oxaliplatin (LOHP) and 5-fluorouracil (5-FU) synergism in advanced colorectal cancer patients (ACRC)
1997
·
V. Meyer
, R. Delva
, et al.
·
European Journal of Cancer
·
5
[beta2-Microglobulin in cancer patients (author's transl)].
1978
·
A Daver
, A Chassevent
, et al.
·
PubMed
·
3
Oral chemotherapy or targeted therapy compliance: An observational multicenter French study in cancer patients.
2014
·
Tatiana Ceban
, Sophie Abadie-Lacourtoisie
, et al.
·
Journal of Clinical Oncology
·
2
[Maintenance of the dose-intensity of chemotherapy combining carboplatin, cyclophosphamide, etoposide in women with ovarian cancer aged 70 and over].
1996
·
R Delva
, M Mege
, et al.
·
PubMed
·
2
Assessing 2-month clinical prognosis in patients with solid tumors: First results of PRONOPALL study.
2011
·
H. P. Bourgeois
, S. Traoré
, et al.
·
Journal of Clinical Oncology
·
1
A multicenter phase II trial of weekly paclitaxel (wPC) and epirubicin (E) in first line metastatic breast cancer (MBC) and pronostic impact of VEGF level.
2009
·
S Abadie
, O Capitain
, et al.
·
Cancer Research
·
1
2134 POSTER Clinical benefit of trastuzumab plus vinorelbine as second-line treatment for women with HER2-positive metastatic breast cancer beyond disease progression
2007
·
P. Chollet
, X. Durando
, et al.
·
European Journal of Cancer Supplements
·
1
Prospective randomized study of mitoxantrone (M) and vinorelbine (V) vs fluorouracil (F), epirubicin (E) or adriamycin (A) and cyclophosphamide (C) in patients with advanced breast cancer (ABC)
1997
·
F. Turpin
, D. Serin
, et al.
·
European Journal of Cancer
·
1
Abstract P1-14-21: High antitumoral activity of neoadjuvant chemotherapy (NCT) with weekly paclitaxel + capecitabine and trastuzumab in patients with locally advanced HER2+ breast cancer (HER2+ LABC): Preliminary results.
2012
·
P Augereau
, P Raro
, et al.
·
Cancer Research
Évaluation d’un pronostic clinique de 2 mois chez des patients atteints d’un cancer du sein : les premiers résultats de l’étude Pronopall...
2012
·
H. P. Bourgeois
, S. Traoré
, et al.
·
Springer eBooks
Abstract #3612: Preliminary results of a phase II trial evaluating efficacy or safety of Trastuzumab plus Vinorelbine as second-line treatment for women with HER2-positive metastatic breast cancer beyond disease progression
2009
·
Xavier Durando
, Thomas Bachelot
, et al.
·
Cancer Research
250 ORAL Peritoneal recurrences arising from ovarian cancer. Results of cytoreductive surgery and intraperitoneal chemohyperthermia
2006
·
G. Lorimier
, D. Dupoiron
, et al.
·
European Journal of Surgical Oncology
Gemcitabine (G) given as a prolonged infusion in patients (pts) with advanced solid tumors: A phase I study with intra-pt dose escalation (DE) and pharmacokinetic (PK) / pharmacodynamic (PD) analysis
2006
·
P. Soulié
, D. Luet
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
31
Citation count:
937
H-index:
10
I10-index:
10
Year
Topic
Type